SCHEDULE 13G/A: FMR LLC and Abigail P. Johnson Disclose 9.9% Passive Stake in Chemours Co.

FMR LLC and its affiliates, along with Abigail P. Johnson, have reported a beneficial ownership of 9.9% of Chemours Co. common stock as of December 31, 2024, indicating a significant passive institutional investment.

Summary

• FMR LLC and Abigail P. Johnson, through various affiliated entities, collectively beneficially own 14,733,562.49 shares of Chemours Co. common stock.
• This ownership represents 9.9% of the total outstanding common stock of Chemours Co.
• The filing is an Amendment No. 12 to Schedule 13G, indicating a passive investment stance.
• FMR LLC holds sole voting power over 14,016,469.90 shares and sole dispositive power over 14,733,562.49 shares.
• Abigail P. Johnson, as a Director, Chairman, and CEO of FMR LLC, is deemed to beneficially own the same aggregate amount of shares as FMR LLC.
• The Johnson family, including Abigail P. Johnson, are the predominant owners of Series B voting common shares of FMR LLC, representing 49% of its voting power, and are considered a controlling group for FMR LLC.
• The filing confirms that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of Chemours Co.

Sentiment

Score: 5

Explanation: This document is a factual disclosure of beneficial ownership and does not contain information that would significantly alter the sentiment towards the issuer, Chemours Co., beyond confirming a significant institutional stake.

Positives

• The disclosure of a significant 9.9% stake by a major institutional investor like FMR LLC and its affiliates may signal confidence in Chemours Co. to the market.
• The passive nature of the investment, as indicated by the Schedule 13G filing, suggests that FMR LLC is not seeking to influence or change the control of Chemours Co. at this time.

Negatives

• The Schedule 13G filing is a routine ownership disclosure and does not contain any negative information regarding Chemours Co.'s financial performance or operational outlook.

Risks

• The document does not detail specific risks related to Chemours Co.'s business operations or financial health, as it is an ownership disclosure filing.

Future Outlook

This Schedule 13G filing is a disclosure of beneficial ownership and does not provide any forward-looking statements or guidance regarding Chemours Co.'s future performance or strategic direction.

Industry Context

This filing reflects a significant institutional investment in a chemical company, which is a common occurrence in the industry as large asset managers build diversified portfolios. It does not provide specific insights into broader industry trends beyond the fact of continued institutional interest in the sector.

Stakeholder Impact

• Shareholders: The disclosure of a significant stake by a prominent institutional investor like FMR LLC may be viewed positively, potentially increasing investor confidence and market liquidity for Chemours Co. shares.

Key Dates

Keywords

Chemours Co, FMR LLC, Abigail P. Johnson, Schedule 13G, Beneficial Ownership, Institutional Investor, Common Stock, Passive Investment, SEC Filing